Atlas Trials

Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia

Clinical trial NCT00762632 · COMPLETED

Trial details

NCT number
NCT00762632
Sponsor
Technical University of Munich
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2007-12-01
Primary completion
2012-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.